耶鲁大学医学院Akiko Iwasaki团队在Science Immunology上发表题为"A B cell screen against endogenous retroviruses identifies glycan-reactive IgM that recognizes a broad array of enveloped viruses的研究论文。

and antibody-dependent cellular cytotoxicity than natural IgM antibodies. IMBiologics is open to licensing and partnering opportunities, including R&D collaboration on ePendy and the company’s ...

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM ...

particularly due to its early-stage development of novel IgM antibodies, which are yet to be proven as viable therapeutic options. The company is confronted with challenges such as the high costs ...

IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) has been assigned an average rating of “Hold” from the eight analysts ...

travelling from abroad to destinations in mainland China must have proof of dual negative results for Covid-19 using both a nucleic acid test and a serological test from IgM antibodies.

Imvotamab (CD20 x CD3) trials in rheumatoid arthritis, systemic lupus erythematosus and myositis ongoing; initial clinical data expected by ...

Nov. 04, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that management will ...

CHENNAI: A seroprevalence study conducted by the State Public Health Laboratory, Directorate of Public Health and Preventive ...